Moderna’s latest COVID-19 vaccine is both approved and ‘made in Canada’ – National

Admin

posted on 2 days ago — updated on 1 second ago

38
views

Descrease article font size Increase article font size Health Canada has approved Moderna’s newly updated COVID-19 vaccine — and for

August 26, 2025 WOL

Descrease article font size

Increase article font size

Health Canada has approved Moderna’s newly updated COVID-19 vaccine — and for the first time, the vaccines will be “made in Canada.”

The company says having the vaccine available from domestic manufacturers and suppliers creates a critical piece of health resilience to “ensure Canada is ready, not just reactive.”

“With this approval, for the first time ever, mRNA COVID-19 vaccine doses for Canadians will be made in Canada. That’s a remarkable milestone,” Stefan Raos, general manager at Moderna, says in an emailed statement sent to Global News.

“This matters for Canadians because COVID taught us that while viruses don’t respect borders, our ability to respond can often be impacted by them.”

Receive the latest medical news and health information delivered to you every Sunday.

Moderna announced the federal regulator authorized its mRNA vaccine known as Spikevax, which the pharmaceutical company says targets the SARS-CoV-2 LP.8.1 variant circulating for fall vaccination.

Story continues below advertisement

Moderna also says the updated vaccine is on track to be available starting in time for the upcoming vaccination season.

1:49
Alberta government reveals cost to get COVID-19 vaccine for most citizens

Trending Now

‘Put American spirits back’ on Canadian shelves, U.S. booze group urges

When could prices start dropping as Canada axes U.S. counter-tariffs?

These vaccines will be made in Canada via facilities in Cambridge, Ont., and Laval, Que.

“This year, all our pre-filled syringe COVID-19 vaccine doses for Canada are on track to be produced entirely within the country, starting at our new mRNA manufacturing facility in Laval, Quebec, and completed at our fill-finish partner in Cambridge, Ontario,” Raos says.

“This end-to-end domestic supply chain enables fast delivery, greater self-reliance, and a more agile response to evolving public health threats.”